07:00 , Sep 26, 2005 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/23 cls Alnylam (ALNY) ThinkEquity Andrew McDonald Downgrade Accumulate (from buy) 14% $11.55 McDonald downgraded the stock because he believes the shares are "approaching...
07:00 , Sep 12, 2005 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/9 cls Abgenix (ABGX) WR Hambrecht Patrick Flanigan III New Buy 5% $12.29 Flanigan set an $18 target. He believes...
07:00 , Aug 1, 2005 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/29 cls Amylin (AMLN) C.E. Unterberg, Towbin Matthew Osborne Downgrade Market perform (from buy) -12% $18.66 Osborne believes that impatient investors may find the...
07:00 , Jun 27, 2005 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/24 cls Acadia (ACAD) Rodman Michael King New Market outperform 0% $9.20 King started coverage of the CNS company with...
07:00 , May 16, 2005 |  BioCentury  |  Finance

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/13 cls ArQule (ARQL) America's Growth Capital David Wood New NA 7% $6.28 Wood expects data at ASCO from a Phase I trial of...